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Abstract Patients presenting with chest pain at an emer-
gency department in the United Kingdom receive troponin
tests to assess the likelihood of an acute myocardial infarc-
tion (AMI). Until recently, serial testing with two blood
samples separated by at least six hours was necessary in
order to analyse the change in troponin levels over time.
New high-sensitivity troponin tests, however, allow the
inter-test time to be shortened from six to three hours.
Recent evidence also suggests that the new generation of
troponin tests can be used to rule out AMI on the basis
of a single test if patients at low risk of AMI present with
very low cardiac troponin levels more than three hours after
onset of worst pain. This paper presents a discrete event
simulation model to assess the likely impact on the num-
ber of hospital admissions if emergency departments adopt
strategies for serial and single testing based on the use of
high-sensitivity troponin. Data sets from acute trusts in the
South West of England are used to quantify the resulting
benefits.
Keywords Emergency department · Diagnostic
pathways · Chest pain · Avoidable admissions · Discrete
event simulation · Case study
1 Introduction
Chest pain is among the most common reasons for atten-
dance at emergency departments (EDs) in the United
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Kingdom (UK) and accounts for up to 6% of all ED visits
per year [16]. This constitutes a population of roughly one
million patients (with levels of attendance varying accord-
ing to patient age, gender etc.). It therefore represents a
significant workload for hospitals and their staff especially
in the context of the trend of increasing ED attendances
in recent years. Many of these ED attendances lead to a
subsequent admission into a short stay ward, e.g. a Med-
ical Assessment Unit (MAU), or into specialised (cardiac)
wards. Such admissions are commonly triggered by the UK
National Health Service (NHS) requirement that EDs avoid
patients staying longer than four hours in the ED. This
4 hour target often leads to admissions into neighbouring
wards, such as Clinical Decision Units (CDU), in order to
avoid breaching the target. Some clinicians argue that, espe-
cially from a patient’s perspective, it is beneficial not to be
admitted, since this will reduce unnecessary tests and med-
ications. Furthermore, whilst CDUs are commonly under
the management of ED staff and transferring patients to
CDUs does not reduce the workload for ED staff, admis-
sions will have a greater adverse impact on a hospital’s
overall financial performance as well as that of the overall
health system.
The likelihood of an AMI is usually gauged from an
assessment of a patient’s medical history, clinical examina-
tion, electro cardiograms (ECGs) and, in particular, serial
cardiac troponin (cTn) tests. Cardiac troponin is a biomarker
of myocardial necrosis and an increased concentration in the
bloodstream indicates damage to the heart muscle. It is not,
however, specific to AMI and various acute and chronic con-
ditions could also lead to elevated cTn levels. In AMI, cTn
shows a specific pattern of rapid increase which, together
with evidence of myocardial ischemia, is used to diagnose
AMI and initiate suitable treatment for the patient. In sus-
pected AMI, cTn is measured in two blood samples taken
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several hours apart in order to distinguish between chronic
conditions with stable increase in cTn concentration and
AMI where rapid change in cTn levels is observed. If both
samples are below a threshold, i.e. negative, and there is no
evidence of rapid change, AMI can be ruled out. If no other
concerns about the patient’s medical condition are present,
such patients can be discharged directly from the ED. If the
change relative to the baseline troponin value, i.e. the first
test’s value, is significantly large, the patient is likely to have
had a heart attack and special cardiac treatment is required
immediately. Until recently, it was recommended that the
first sample is taken at the patient’s presentation to the ED
and the second 10-12 hours after the onset of symptoms to
allow enough time for the troponin values to rise and to be
detected by the test [33]. The recently published guidance
by the National Institute for Health and Care Excellence
(NICE, [24]) suggests that with the high-sensitivity cTn
assays the inter-test time could be made shorter to allow
early rule-out of AMI in patients at low risk of the condition.
According to these recommendations, in low risk patients,
two blood samples – one at presentation and one three hours
later – achieve sufficient accuracy to rule out AMI provided
the patient does not present within three hours of symptom
onset. Figure 1 explains troponin values as a function of
time since onset of pain. It is also highlighted how recom-
mendations by the NICE committee affect the practice of
testing. Apart from serial testing, decisions can be based on
a single test if the blood sample is taken at least six hours
after the onset of worst pain.
The main focus of the research project was to investigate
how the introduction of high-sensitivity cardiac troponin
tests affected current practice at hospitals in the South West
of England. Our study was conducted in collaboration with
the South West Academic Health Science Network (SW
AHSN) and acute trusts in the South West of England [2].
We worked in an interdisciplinary team with clinicians at
the different hospitals, information specialists, public health
and diagnostic research and operational researchers. Project
results indicated significant improvements in reducing the
number of hospital admissions [28]). Finally, recent studies
report that some low risk patients could be safely discharged
on the basis of a single negative test if they present more
than three hours after the onset of worst symptoms and
have very low levels of cTn [8, 11, 31, 37]. Our study aims
to support EDs to effectively manage staff workload and
to reduce the number of avoidable admissions from ED
into hospital. The impact of pathway reconfigurations on
these goals is addressed using suitable performance met-
rics identified in this paper and we discuss the following
research questions:
1. What are the relevant performance metrics when look-
ing at diagnostic pathways for chest pain patients?
2. How can evidence-based pathway changes be assessed
using a discrete event simulation model?
3. How do the identified key performance indicators
(KPIs) change if the inter-test interval is shortened to 3
hours?
4. How do strategies incorporating single test rule-out
affect KPIs compared to current practice?
5. What are barriers and facilitators of a discrete event
simulation study looking at a redesign of diagnostic
pathways for chest pain?
In the following sections we provide necessary back-
ground information about the scope of this research project
and discuss relevant literature in order to highlight the
research gap this study aims to bridge (Section 3). This
is then followed by a discussion of available data sets
and suitable performance metrics in Section 4. The dis-
crete event simulation model which will be presented in
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Fig. 1 Changes in troponin concentration over time for different medical conditions, i.e. acute myocardial infarction versus other causes of
chest pain
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Section 5 merges project requirements and available data.
We will finally use the model to conduct what-if analyses
(Section 6). The last section discusses key findings of this
study together with its limitations.
2 Related literature
A literature review for this project bears on two distinct
areas of research which are jointly analysed. Firstly, diag-
nostic accuracy research and, more specifically, the accu-
racy of high-sensitivity cTn troponin tests, is a key input
for our study. We analyse publications looking at pathway
changes following the introduction of high-sensitivity cTn
assays and their use with protocols for early rule-out of
AMI. Secondly, discrete event simulation (DES) models
have been widely used to model patient flow through emer-
gency departments. This is narrowed down and the focus of
this review is on studies in which the purpose of the mod-
els is to evaluate changes to existing pathways. Finally, we
discuss this paper’s contribution bringing together the two
threads of literature and research.
2.1 Diagnostic testing and accuracy of troponin tests
Cardiac troponin tests are regarded as the gold standard for
diagnosis of AMI. Previous versions of these assays, how-
ever, lacked the diagnostic sensitivity necessary for safe
rule-out of AMI in the first few hours after patient presen-
tation at the ED. As a result, a second measurement 10–12
hours from the onset of symptoms was recommended to
avoid inadvertent discharge of patients with evolving AMI
[33]. In the last five years, new sensitive and high-sensitivity
assays have been developed, which are able to identify very
small concentrations of cTn. These can reliably quantify
levels below the 99th percentile of a healthy reference pop-
ulation used as a positivity cut-off for AMI. This makes it
possible to identify increased levels of cTn early in the diag-
nostic process and to avoid long delays before AMI is finally
ruled out.
In 2014, NICE issued guidelines recommending the use
of high-sensitivity cTn assays for early rule-out of AMI
[24]. Given the significant differences between the available
cTn assays branded as sensitive or highly sensitive, NICE
felt obliged to define a high-sensitivity cTn assay as those
that meet the following two criteria: has a coefficient of vari-
ation of 10% or less at the 99th percentile (the upper limit
of the reference population) and is able to detect cTn in at
least 50% of the reference population. Only three assays met
these criteria and only for two of them, the Elecsys Troponin
T high-sensitive (Roche Diagnostics) and the ARCHITECT
STAT High-Sensitive Troponin-I assay (Abbott Diagnos-
tics), sufficient evidence was identified to recommend their
use in clinical practice. The NICE guidance recommends
that for low risk patients these assays could be used, in con-
junction with all relevant clinical information, to rule out
AMI early in the diagnostic process. Such protocols should
be based on two samples taken at least three hours apart; the
manufacturer-recommended cut-off based on the 99th per-
centile together with changes in cTn levels should be used as
a decision threshold; and additional factors that might affect
the performance of the test, such as the time elapsed from
the onset of symptoms, the baseline cTn level and patients
risk factors should be considered when making a decision.
It was hoped that such early rule-out protocols could help
avoid unnecessary waits and hospital admissions of patients
who do not have AMI or other life-threatening conditions
and that such patients could safely be discharged from the
ED.
The recommendation to make a decision based on the
change in cTn concentration between two blood samples
reflects the need to distinguish between chronically ele-
vated baseline troponin and the acute pattern of increase
typical for AMI. Chronically elevated troponin could be
observed in a range of medical conditions, such as pul-
monary embolism, chronic heart failure, and coronary artery
disease and also in patients with impaired renal function.
Also, the baseline level of cTn is age-dependent and a sig-
nificant proportion of older patients, especially those over
75 years of age, will have baseline cTn above the 99th
percentile without having an AMI or another cardiac condi-
tion. For instance, [26] found that the median (inter-quartile
range, IQR) value of Elecsys Troponin T high-sensitive in a
reference population of presumably healthy individuals var-
ied significantly across age groups. It was 6.33 ng/L (IQR:
4.1–9.4) in 50–75 years old, 28.6 ng/L (IQR: 23.5–37.9) in
75–95 years old and 48.5 ng/L (IQR: 39.3–68.5) in those
>96 years old.
Although considering the change in cTn levels over time
may help avoid misclassification of cases where cTn is ele-
vated due to non-AMI reasons, in practice this leads to a
significant delay in making a decision about admission or
discharge. Given the expectation within NHS that at least
95% of ED patients should be discharged or admitted to hos-
pital within four hours of their presentation, implementing
the above recommendation means that most of the patients
will be admitted regardless of their level of risk and the
result from the first cTn measurement. Once admitted, such
patients will need to spend time in hospital until the result
from the second blood sample is received and a consultant
is available to make a decision.
Alternatives to this strategy have been proposed tak-
ing advantage of the fact that in patients with very low
pre-test probability of AMI and Acute Coronary Syndrom
(ACS), very low baseline cTn levels make the possibility of
AMI highly unlikely [8, 11, 31, 37]. If incorporated in the
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diagnostic pathway, such an early rule-out protocol could
help avoid unnecessary tests and admissions for patients
who do not have AMI but present with chest pain and have
had cTn measured at presentation. Such a strategy does not
obviate the need for a second cTn measurement which, for
many patients, will still be required to rule out AMI. Also,
such a strategy is not applicable to patients who present
less than three hours after onset of symptoms because, as
the studies referred to above suggest, the risk of AMI being
missed in such patients is still considerable.
2.2 Pathway redesign in emergency departments
ED departments and their processes have been repeatedly
modelled from a variety of perspectives. A recent overview
in [17] outlines this variety in terms of resulting research
questions. Many of the existing papers in this area study
reasons for excessive patient waits and discuss strategies to
overcome crowded emergency departments [25, 30, 34, 36].
Patient flows and overcrowding of departments appear to be
common themes in recent years [12], both of which resonate
with the purpose of our work.
DES is among the most commonly used techniques in
healthcare operational research [22] and has been repeatedly
deployed to address problems in ED [6], even to the extent
that generic templates have been proposed [15], although
these have not met with unanimous approval [12]. Common
outcome measures of ED models appear to be the time spent
in department, patient throughput and resource utilisation
[6]. On the other hand, the costs of Emergency Depart-
ments appears to be an under researched topic [17]. The
vast majority of models are very unit specific. Approaches
taken include assessment of working practices [1, 3–5],
shift patterns [5], equipment bottlenecks [9], and in some
cases, patient pathways themselves [20]. Interactions of ED
patient flow with the wider hospital context are clearly also
important [7], and examination of these interactions can be
achieved using DES models, or sometimes may be better
analysed by other techniques [29, 32].
A recent trend has been the use of operational research
models and methods, including DES, to address the flow
of both sub-populations within ED, as well as aspects of
specific treatment pathways, e.g. the time to treatment in
acute stroke in which ED is closely involved [20]. Clearly,
many EDs are resource limited and whereas purchase of
equipment or extra staffing may not be an option [5], time
and resource saving interventions that utilise existing staff
may clearly be beneficial. With regards to high-sensitivity
troponin, these topics have also been explored in clinical
trials [31]. Whilst allowing for some assessment of impact,
such investigations tend to be either expensive or time
consuming, and do not allow the researcher to find the opti-
mal combination of process changes in terms of resource
and time benefits. Therefore, whilst there is evidence that
high-sensitivity troponin testing (in particular single versus
multiple point testing) is likely to be beneficial and safe, it
is unclear how it should be implemented and what the actual
benefits might be.
2.3 Contribution of our study
All of those issues outlined above are at the core of this mod-
elling project and will feature in the concluding discussion.
The main aim of our study is to bring together operational
research and the management of diagnostic pathways. We
therefore refer to the work of e.g. [31] and [20], yet we
clearly use a different focus. In comparison to the study
by [20], our approach focuses on a different patient sub-
population attending ED (patients with chest pain), consid-
ers national guidelines together with medical evidence and
assesses effects on the number of admissions and discharges
when a new diagnostic strategy is introduced. In particu-
lar, our study focuses on low risk patients presenting at ED
and we investigate changes to a diagnostic pathway rather
than to a treatment pathway. Our study can also be disso-
ciated from clinical trials such as [31], as a discrete event
simulation study provides a number of major advantages,
i.e. time and cost savings, the ability to update the model as
the parameters of the analysis change, and mitigation of the
risks of introducing change directly. Furthermore, trials do
not take account of the local context which might be differ-
ent from hospital to hospital. Using local routine data makes
it possible to consider local structures and processes and to
explore how new strategies would work locally, allowing for
the uncertainty in different scenarios.
To summarise, the simulation model presented here acts
as a support tool for clinicians and decision makers at hospi-
tals. It provides a means to quantify various changes to path-
ways in terms of the numbers of admissions and discharges,
but still requires a clinician’s judgement to determine which
of those options should be chosen. The expert’s opinion is
key in this case, because some decision making factors can-
not be appropriately quantified yet need to be taken into
account.
3 Diagnostic pathways for chest pain
Capturing the current diagnostic pathways for chest pain in
ED was a major step in the analysis of current practice at
the collaborating trusts. Clinical protocols and discussions
with clinicians during mapping sessions provided valuable
input to develop a suitable pathway model. In this section,
we firstly present a generic pathway as one of the key
outcomes of these analyses and meetings. A set of rele-
vant performance metrics is another key outcome which we
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discuss subsequently. Note, that these performance metrics
can be represented through different data, subject to their
availability at the hospitals. We revisit this in Section 5 after
introducing the available data for this study (Section 4).
3.1 Generic pathway
A key task of this project was to explore the impact of
high-sensitivity troponin tests on current practice at the hos-
pitals. This was done by capturing the various diagnostic
pathways on whiteboards (and later refined versions on
paper and digital) during a series of meetings with inter-
disciplinary hospital teams. Visualising current practice in
terms of patient-focused pathways helped to describe the
sequence of necessary tasks which are performed if a patient
with chest pain presents at the ED.
Although individual protocols at the hospitals differed,
a common pathway could be developed which is informed
through the various meetings held across hospitals in the
South West of England. The explicit focus of this project
was on the management of patients at low risk of AMI.
Patients presenting with a high-risk features, such as ongo-
ing anginal chest pain or ST-segment elevation on the ECG,
will be admitted regardless of the first troponin result and
will not follow the clinical pathway described below [23,
24]. Figure 2 represents the generic steps of such a pathway.
The dashed boxes at the beginning of the process high-
light the two main ways of arriving at the hospital: Patients
arrive by either ambulance or any other means of trans-
portation which we refer to as self-presenting since they do
not require medical assistance during the transport. Self-
presenting patients register their attendance at reception
before they are triaged. Ambulance patients usually bypass
registration and go straight to triage. The first blood sample
is taken during the first medical assessment which is nurse-
led at some of the trusts. Once the blood has been drawn,
the sample is dispatched to the laboratory to be analysed
and, finally, results are reported electronically and made
available to clinicians via the hospital’s information system.
After this first assessment, patients usually wait in an ED
waiting room to be seen by a senior doctor or consultant.
A decision on further management and treatments for the
patient is made during the second assessment. Depending
on the time interval between onset of pain and first sam-
ple taken at hospital, either a serial or a single test strategy
can be performed. If the first blood sample is taken at least
six hours after the onset of worst pain and the outcome is
negative a patient can be discharged safely, if the doctor
has no other concerns (single test strategy). According to
the patient’s overall medical condition, the discharge could
require a follow-up meeting with a GP. A positive first sam-
ple taken more than six hours from onset of pain will lead to
an admission into specialised care. A second test is usually
required if the first sample is taken earlier than six hours
from onset of pain regardless of the outcome of the first test
(serial test strategy). NICE [24] currently does not recom-
mend decisions based on a single test, even if negative. For
this second test, patients are usually admitted to either CDU
or MAU, where blood is drawn again and a sample is sent
to the laboratory for analysis. Once available via the hospi-
tal’s information system, the results for the two samples are
jointly analysed and a decision is made whether to admit
or discharge the patient. On rare occasions patients need to
be admitted into cardiac care or other areas of specialised
care, those are summarised under Admit: ward (inpatients).
A very small number of samples (not more than 3%) need
to be repeated because the initial sample is haemolysed and
cannot be used for analysis.
This generic description of the diagnostic pathway
reflects the practice of most of the acute trusts in our study.
However, there are some minor differences which are not
relevant to this study. Some of the trusts do have short
stay wards under the management of ED, some only have
an MAU which is generally not under management of ED
staff. There are also distinctions in terms of responsibilities
for taking blood samples. Some hospitals require this to be
done by a doctor (sometimes during a see and treat assess-
ment), whilst others allow this to be performed by suitably
qualified nurses. These disparities mean that it would be
challenging to transfer examples of good practice between
hospitals in our study, an important implication for the
implementation of any proposed changes at specific EDs
(however these aspects were outside the scope of our study).
The case study presented below focuses on one of the
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Fig. 2 Generic patient pathway in ED for patients presenting with chest pain at low risk of AMI
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collaborating trusts for which the generic pathway accu-
rately represents the hospital’s actual ED pathway.
3.2 Performance metrics
Discussions with clinicians identified the following two
main performance metrics which are closely linked; the
number of admissions and the resulting workload for ED
staff. The number of admissions into hospital not only
impacts a hospital’s financial performance but it mainly
causes additional workload. Also, the length of stay in the
department is relevant to any patient attending ED. We will
briefly discuss why these metrics are important to assess the
performance of an ED.
3.2.1 Number of admissions
Admissions following the ED attendance caused by a sus-
pected heart attack occurs with the majority of patients. For
hospitals this increases their payments even if the patient
is ’only’ admitted to a short stay ward. From a different
perspective, this leads to higher tariffs being paid and thus
higher costs for the commissioner. As chest pain is among
the most common reasons for ED attendance (approxi-
mately 2.4% to 6% per year [16]), medium-sized trusts have
to deal with 8,000 patients or more every year. For the vast
majority of patients, an admission into hospital would not
have been necessary as they left the hospital without admis-
sion into specialised care. Hence, reducing the number of
those admissions would reduce workload particularly for
short stay wards.
3.2.2 Number of single test decisions
The above criterion is closely linked to the number of
decisions based on a single test. Current practice is that
a decision is made on only one sample if the time inter-
val between the onset of pain and the first blood test is
sufficiently large. According to studies investigating pre-
hospital delays of patients, the probability of patients having
blood taken less than six hours from onset of pain is very
high. With the introduction of single test rule-out strategies
based on high-sensitivity troponin, this time limit could be
lowered from six hours down to four hours or less. This
reduction will increase the number of decisions based on
a single test and also positively influence the number of
patients cared for by ED staff on short stay wards such as
CDUs.
3.2.3 Length of stay
Apart from patient volume data, the length of stay in the
emergency department is another key metric. In England,
the Department of Health introduced the 4 hour target for
EDs in 2004. This guideline demands that 95% of all atten-
dances should have spent not more than four hours in ED
[14]. In addition, the combined length of stay in both ED
and on a short stay ward, particularly the CDU, is of simi-
lar importance. Reductions in either time interval mean that
patients require less attention or observation from ED staff
whilst in ED or CDU respectively.
Our simulation study investigates two potential changes:
(1) reducing the inter-test time only and (2) reducing the
inter-test time together with the limit for a single test
strategy, i.e. the minimum required time between onset
of pain and the first blood sample taken at ED. Both
these options allow us to assess the number of admis-
sions and hence quantify the beneficial effects of high-
sensitivity troponin tests. Clearly, a shorter time between
two blood samples reduces a patient’s overall length of
stay in hospital and particularly the time spent on a
short stay ward. In this case, the number of admissions
might not necessarily change, yet the time during which a
patient needs to be cared for on short stay wards could be
reduced.
4 Data analysis
Historic data sets from the collaborating trusts were anal-
ysed in order to better understand the current use of troponin
tests across the South West of England. The available data
records were then employed to populate the DES model.
Most hospitals provided background data for the patient
cohort such as age, gender or mode of arrival. The avail-
able time stamps allowed us to investigate typical key
process times, e.g. arrival to triage or arrival to sample.
Clinical information, such as presenting complaint (i.e. the
symptoms a patient describes during registration), working
diagnosis (usually determined by a clinician or nurse dur-
ing assessment), number of troponin tests and numerical
test outcomes, were also provided. Either presenting com-
plaint or working diagnosis was used as a filter criterion
by hospitals’ information departments to identify the appro-
priate population of interest. Medical doctors within our
research team then checked free text fields – where avail-
able – describing the presenting complaint for consistency,
i.e. whether the complaint recorded matched the diagno-
sis one would expect with acute coronary syndrome. The
analyses of the data revealed very similar structures across
the different trusts. Therefore, the presented figures can be
considered representative for acute hospitals in the South
West of England. There are differences in terms of volume
data and the resulting absolute figures, but ratios relative
to the number of patients considered are at very similar
levels.
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4.1 Patient cohort
For the case study presented in this paper we use data
from one of the hospitals (Trust A). A total number of over
8,200 patient episodes over a period of 12 months were
included in the analysis. This marks the largest data set
obtained for this study. Out of seven participating trusts,
five provided data over a period of at least 12 months
ranging between 1,200 and 8,200 patient episodes. This
indicates different sizes of catchment areas for the collab-
orating hospitals. The share of male patients attending ED
was higher (56%) than female (44%) patients for this trust.
The share of male patients ranged from 55% to 59% across
the trusts. Male patients also were on average younger (60.1
yrs) than female (61.6 yrs) patients. The overall population
average for Trust A was 60.8 years with a median of 64.
Again, this is in line with data across the trusts, where
male patients were on average between 56 and 63 years
old and between two to four years younger than female
patients. In general, the share of women increased in higher
age categories, especially among attendees older than 75
years. The likelihood of requiring medical assistance to get
to the hospital, i.e. travelling via ambulance, significantly
increased with the patients’ age. Across all trusts, between
69 and 76% of all arrivals were ambulance arrivals. One
might expect this share to be higher in rural areas due to
limited easy access to other means of transportation such
as public transport but we did not identify such structural
differences.
From observation there appears to be no seasonal pattern
in the attendance, but a difference in weekdays and week-
ends is apparent. The most important feature is a typical
intra-day variation in arrivals; all these effects are shown in
Fig. 3. The level of attendance typically reached its max-
imum around noon and its minimum during night hours
and very early mornings. Although attendance decreased
from noon until midnight there were minor peaks, usually
around 6 pm. This pattern demonstrates that most patients
with chest pain attend an emergency department during
morning times (possibly before work) or after work as the
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Fig. 4 Compared length of stay in ED for patients arriving by ambu-
lance and self-presenting compared. Dots within the boxes represent
the mean length of stay for ambulance arrivals (206.3 min) and
self-presenting arrivals (187.3 min) respectively
afternoon peak suggests. This pattern becomes less notable
with increasing age because older patients are more likely
to have a serious cardiac condition and thus attend the
ED whenever necessary. A distinction between ambulance
arrivals and self-presenting patients showed a pattern very
similar to those mentioned above with ambulances arrivals
proportionately higher due to higher volume in attendance.
4.2 Process times
The collaborating trusts provided various time stamps which
mark the start of the pathway related activities (see Fig. 2).
This allowed us to analyse start-to-start relations of activi-
ties and measure relevant process times. Most of the process
times were linked to the arrival pattern and thus the resulting
workload, i.e. processes tended to take longer during busy
periods and length of stay in ED was longer for patients who
arrived by ambulance since ambulance arrivals very often
presented with a more severe condition. The boxplots in
Fig. 4 highlight slightly longer length of stays for ambulance
arrivals – both on average and in general as indicated by the
shifted inter-quartile limits. Patients who were subsequently
admitted to hospital tended to stay longer in ED. The level
of attendance is naturally linked to the inter-arrival times.
Figure 5 depicts the time between two arrivals according to
means of transportation. Higher variation can be observed
here with non-ambulance arrivals. This underlines that more
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Fig. 5 Inter-arrival times for patients presenting with chest pain at
ED. On average, self-presenting patients arrived every 202.1 min and
ambulance arrivals occurred every 93.1 min (indicated by dots within
the boxes)
serious causes of chest pain are linked to ambulance arrivals
and these patients decide to attend the ED when they expe-
rience pain rather than delaying their attendance, e.g. until
after they finish work. The time from arrival to triage is only
relevant for non-ambulance arrivals, because for ambulance
arrivals, delays before triage could only occur while the
ambulance crew hands over a patient to clinical staff. The
latter, however, would not affect the length of stay in ED
because the attendance technically starts with the triage after
the patient was handed over. For non-ambulance arrivals, the
average time from arrival to triage was 23 min (SD 28 min).
Waits before triage were shorter during less busy times of
the day (mean 18 min, SD 22 min) and longer during peak
times respectively (mean 30 min, SD 35 min).
The time between arrival at ED and when the first blood
sample taken is crucial to inform a doctor’s decision whether
a patient is eligible for either a single or a serial test strat-
egy. The intra-day variation within the time interval between
arrival at ED and the first blood sample taken varies over
the day (see Fig. 6). During less frequented times of the day,
i.e. during early morning hours, the difference between the
overall daily average (dashed line) is significant. With rising
numbers of arrivals towards noon and afternoon, the hourly
average time until a first blood sample is taken is close to
and above the plotted overall daily average (mean 55.7 min,
SD 42.4 min). The total turnaround times for blood sam-
ples, i.e. the time including transportation and analysis until
results are finally made available via the hospital’s informa-
tion system, are on average 91.2 min (SD 86.3 min). In less
than 3% of all cases, a blood sample cannot be used when
arrived at the laboratory, i.e. it is haemolysed. This requires
a new blood sample to be taken, transported and analysed.
Those rare cases are not considered in the average time pre-
viously mentioned but are incorporated within the discrete
event simulation model.
4.3 Impact of the 4 hour target in ED on test strategies
The strategy of serial troponin testing will almost always
lead to admissions into CDU or MAU where the second
blood sample is drawn and a final decision about admission
or discharge is made. Through these admissions, breaches
to the 4 hour target are avoided since it is likely that, after
the second blood sample is taken, the timespan of arrival
to first sample plus the inter-sample time add up to at least
240 min on average (see Fig. 7). Short stay wards attached
to an emergency department, such as CDUs, are usually
under control of ED staff. Hence, a reduction of the overall
length of stay through an earlier discharge from short stay
wards is likely to reduce workload for clinicians, nurses and
administrative staff working in ED as well as removing the
involvement of other departments and staff at the trust (i.e.
it simplifies the patient pathway and reduces the time during
which a patient receives care).
4.4 Assumptions due to unavailability of data
Not all information needed to populate the simulation model
could be derived from existing data records. The time
between onset of worst pain and drawing the first blood
sample is crucial, because it triggers whether a single or
serial test strategy needs to be performed. Unfortunately,
this interval is only partially available through routinely col-
lected data. We therefore separated out the time from onset
of worst pain to arrival at hospital (pre-hospital delay) and
the hospital process arrival to first sample in order to pro-
vide suitable replacements for the pain to sample time as
shown in Fig. 8. However, since most of the trusts did not
routinely record the time from onset of pain to arrival at
the hospital, we made use of available studies from aca-
demic literature. Out of numerous studies on pre-hospital
delays [10, 18, 19, 21, 27] only few were suitable for this
comparison because they took into account conditions sim-
ilar to those in our study. In particular, we focused on two
Fig. 6 Timespan arrival to
sample by hour of day. The
dashed horizontal line represents
the overall daily average
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Fig. 7 Simplified pathway
explaining the likelihood of
breaching the 4 hour target
when using a serial test strategy 4 hour target in ED
Arrival at 
hospital (ED)
1st sample 
taken (ED)
2nd sample 
taken (CDU)
≥ 180min≈ 60min Review of
2nd sample 
≈ 45min
publications which report a study conducted in the UK
and one focusing on the likely differences in delays when
looking at onset of first and worst pain. The probability dis-
tributions in Fig. 9 follow a very similar pattern and there is
only a little difference between the UK study in [27] and the
worst pain to sample interval reported in [19]. In all studies
the reported data follows a log-normal distribution with dif-
ferent parameters with a mean varying between 210 min and
360 min— the median is roughly 140 min (± 15 min). How-
ever, the standard deviation varies significantly between 290
min and 560 min. The distribution we used as a start in this
study had a mean of 360 min and a standard deviation of
roughly 240 min. We found that using published data for our
setting overestimated the number of patients who arrived
in time to be managed on the basis of a single test only.
By reducing the modelled delay in increments of 30 min-
utes we found that a mean pre-hospital delay of 300 min
(together with an adjusted standard deviation of 250 min)
gave the best agreement with the trust data in terms of the
number of patients receiving single or serial test rule out.
This likely accounts for the apparent differences in travel
times compared to the pre-hospital delays reported in [27].
Figure 9 shows how the chosen distribution for our model
differs from other studies.
4.5 Modelling of acuity levels of patients
Together with clinicians and diagnostic experts, we devel-
oped four major categories of patients which can be inter-
preted as umbrella terms for the summarised diagnoses. We
distinguished (1) high-risk and low-risk patients, the latter
being further explained through (2) cardiac, (3) musculoske-
letal and (4) other reasons of chest pain. In our simulation
model, based on the data provided from Trust A, only
1.7% of patients are at high risk. The remaining groups
account for 31.1% (cardiac causes), 28.6% (musculoskele-
tal causes), 38.6% (other causes) of the attending population
respectively. Published research papers revealed two major
patterns which troponin values could follow over time as
previously shown in Fig. 1. Patients with AMI have a fast
increase in their troponin concentration shortly after the
onset of pain [10, 35], whereas with other medical con-
ditions, e.g. musculoskeletal causes of chest pain, it is
common that troponin concentration varies around a nor-
mal level. According to the patients’ acuity levels, distinct
troponin profiles over time were modelled to incorporate (1)
a rapid increase in the concentration for high-risk patients
and (2) a natural variation around a baseline concentra-
tion (see appendix). Performing serial testing captures the
change in troponin values over time. A significant increase
in the level of troponin would be an indicator for AMI. Con-
versely, only small changes in the level of this biomarker
indicate that the heart muscle is not severely damaged and
can be considered due to natural variation or a chronic con-
dition. Upon arrival of patients in our model, we assigned
the acuity level to patient-specific label which e.g. helped to
route patients to cardiac wards and other specialised care.
4.6 Making use of historic data
We used basic maximum-likelihood fitting provided
through dedicated R packages such as fitdistrplus or
rriskDistributions to estimate key parameters for the distri-
butions. All process times within the ED and the laboratory
could be accurately described using gamma distributions.
The most appropriate way to identify suitable distributions
was to inspect the shape of histograms before estimat-
ing parameters for the respective candidate distributions.
We focused on commonly used exponential, gamma and
log-normal distributions as suitable candidates. We then
inspected historical against theoretical quantiles for eligi-
ble distributions using quantile-quantile plots (QQ plots).
This was necessary since the quality of statistical methods
usually employed to test for a certain distribution is very
low with large sample sizes. The inter-arrival times for both
modes of arrival could also best be modelled using a gamma
distribution. Again, this was accurately visualised using QQ
plots. We decided to separate out the inter-arrival and pro-
cess times in intervals of four hours starting at midnight.
This is in line with recent publications in healthcare and
Fig. 8 Process times from onset
of pain to (a) arrival and
(a) blood drawn explained
together with available proxies
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Fig. 9 Adjusted distribution modelling the pre-hospital delay com-
pared to distributions reported in suitable studies in the literature
leads to sufficient level of detail [13]. The pre-hospital delay
was best described in terms of a log-normal distribution.
5 Discrete event simulation model
We modelled this diagnostic pathway for patients with
chest pain using Simul8 (Simul8 Corporation). The DES
model depicted in Fig. 10 is based on the generic pathway
outlined in Fig. 2. The underlying structure evolved over
a number of pathway mapping sessions with multidisci-
plinary teams at hospitals across the South West of England.
During those meetings the current practices at the hospitals
were captured which also allowed to explore how close the
current practice was to the respective clinical protocols.
5.1 Model logic
Patients arrive with inter-arrival times sampled from a time-
depended gamma distribution which is separately defined
for ambulance and non-ambulance arrivals. Each patient is
assigned a diagnostic category, i.e. high-risk or low-risk
with different causes of chest pain. Only non-ambulance
arrivals register, before all patients are triaged and a first
blood sample is drawn. Here, the work item is duplicated
to individually simulate the process of analysing the blood
sample. The time between patient arrival and first blood
Trop < 14 ng/l
Time since
onset > X
yes
no
Take 2nd sample
outside ED at 3hrs,
assess troponin
yes
no
Take 1st blood
sample
trop >20%yes
no
Discharge
(single test)
Admit if
necessary
Discharge
(single test)
Fig. 11 Simplified decision logic within the DES model for low risk
patients to determine whether single or serial strategy is applied
sample taken together with the pre-hospital delay records a
patient’s first troponin value once the sample has arrived at
the lab. While this takes place, the patient in EDmoves on to
be seen by the doctor and, if troponin test results are avail-
able, a decision is made. In our model, medical decision
making uses two characteristics, namely a patient’s medical
condition and the resulting level of troponin as the key fac-
tors. Those factors drive further management of the patient
(i.e. whether it is appropriate to discharge the patient or
whether an admission together with a second sample or even
further treatment is required).
Figure 11 highlights the underlying decision principle
which simplifies the original clinical protocol and has been
discussed with, and approved by, collaborating clinicians.
If the sample is taken more than six hours from onset of
Fig. 10 Screen capture of the
DES model developed for
Trust A using the software
package Simul8. The blocks
(arrivals, ED, laboratory,
hospital admissions and
discharges) visualise key
elements of the diagnostic
pathway
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Table 1 Model validation comparing key parameters of the simulation
model with historic data and deviation relative to historic values
Parameter Historic DES model Deviation
Attendance
Ambulance 5659 5637 0.40%
Self-Presenting 2580 2662 3.20%
LOS in ED (in min) 200.33 201.69 0.70%
Outcome
Discharges (single test) 1660 1749 5.40%
Admission CDU 1815 1758 3.10%
Admissions MAU 4015 4039 0.60%
Other admissions 749 745 0.50%
pain a decision on whether to admit or discharge a patient
is made based on the troponin level and the overall medi-
cal condition of the patient, i.e. patients at low risk with a
negative test and no other symptoms could be discharged.
Patients presenting with high risk (i.e. clear symptoms of
a heart attack) will be admitted regardless of the outcome
of the troponin test. Those admissions are mainly based on
assessing the patient’s medical condition, the medical his-
tory, and other tests, in particular ECG. All patients with
time since onset less than X hours (this is the hospital’s
choice) are then admitted to either MAU (positive first test)
or CDU (negative first test) where a second blood sample is
taken at least three hours after the first one. At this stage, the
work item is again duplicated to capture the blood sample
being sent to the laboratory for analysis. Once those second
test results are available, a decision is made and patients are
either admitted (given the change in troponin is significantly
large) or discharged.
Initially, a generic prototype model was developed to
represent the similarities in the diagnostic pathways for
patients with chest pain across the participating trusts. This
prototype model was subsequently tailored around prac-
tice at the acute hospitals. For instance, at Trust A it was
common to have a review of troponin test results sepa-
rate from the consultation, i.e. the consultation took place
regardless of results being available. A separate consultation
then assessed the results once they became available. Deci-
sion makers and clinicians can use a dedicated interface to
change model parameters such as threshold for single test
strategies and the inter-test time for serial testing.
5.2 Model validation
The validation of our model was done as a comparison of
key model parameters and performance indicators against
historic data. We performed a trial with 100 independent
runs over a whole year and the results are shown in Table 1.
For all relevant performance criteria, i.e. length of stay and
the numbers of admissions and discharges. A sufficiently
accurate representation of the current situation could be
observed. The model slightly underestimates the number
of admissions into CDU and, conversely, slightly overes-
timates the number of discharges based on a single test.
This might be due to the troponin variation over time being
modelled as a moving average process.
6 Simulation study
In order to investigate how both NICE guidelines and addi-
tional clinical evidence affect key performance indicators
we specified a number of what-if scenarios. We compared
the current system to those scenarios and quantified changes
Table 2 Absolute changes in length of stay in ED only and ED and CDU when complying with NICE guidelines and clinical evidence
Scenarios Limit for single testing /inter- Time in ED&CDU (in min) Time in ED only (in min)
sample time (in min)
Average 95% Conf. Int. Average 95% Conf. Int.
Status Quo 360 / 360 546.24 [545.99, 546.48] 201.69 [201.51, 201.87]
NICE 360 / 180 366.24 [365.99, 366.48] 201.69 [201.51, 201.87]
S1 330 / 180 361.18 [360.90, 361.45] 198.45 [198.27, 198.63]
S2 300 / 180 355.66 [355.32, 355.99] 195.98 [195.81, 196.16]
S3 270 / 180 348.70 [348.35, 349.05] 193.89 [193.71, 194.07]
S4 240 / 180 347.84 [347.49, 348.19] 193.62 [193.44, 193.80]
S5 210 / 180 343.25 [342.92, 343.58] 192.23 [192.05, 192.41]
S6 180 / 180 335.22 [334.79, 335.65] 190.38 [190.20, 190.56]
S7 150 / 180 322.06 [321.52, 322.60] 189.30 [190.20, 189.48]
S8 120 / 180 319.98 [319.39, 320.57] 189.15 [188.96, 189.33]
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in length of stay in ED, length of stay in ED and CDU
combined and finally the numbers of discharges versus
admissions into CDU.
6.1 Study design
In total, nine different what-if scenarios were studied in
comparison to the current system (see also Table 2). Sce-
nario NICE modelled the recommendations made in the
NICE guidelines, i.e. reducing the inter-test time from six
to three hours. As shown in the Table 2, all other scenar-
ios incorporate the newly suggested inter-sample time of
180 minutes. Scenarios S1 to S8 shorten the time limits
for single test strategies in steps of 30 minutes. We con-
ducted trials in which we simulated a whole year over 100
independent runs. No warm-up period was specified as this
was not required given the dynamics of the model. The
confidence intervals around the simulated mean were suffi-
ciently small across the performance indicators. The CDU
at Trust A can usually take up to 20 patients and is equipped
with beds and chairs. At the same time, no more than 40
patients can be admitted into MAU. The MAU is occasion-
ally sub-divided to assign beds to medical specialities when
required.
6.2 Results
As previously discussed, the reduction of inter-test time did
not affect the number of admissions at all as the second
sample was always taken after a patient had been admit-
ted (typically into CDU) regardless of the time between
blood samples. Thus, only the time spent in ED and CDU
was affected by adapting to national guidelines. A general
overview of the impact on length of stay in ED only and in
ED and CDU combined is shown in Table 2. Lowering the
limit for single test rule-out strategies shortened the length
of stay in ED and also the overall length of stay in ED and
CDU. The shorter stays (which include short stay wards)
resulted in less busy departments because the number of
CDU admissions also decreased significantly with a lower
time cut-off for single test strategies. Shorter times only in
ED were closely linked to the increase in the number of
discharges directly from ED. Generally, patients spent less
time between having their blood test reviewed and leaving
the department when they were subsequently discharged.
This means that with more discharges directly from ED (and
thus fewer admissions) the time in ED could be reduced
by up to 12 min on average. A bigger reduction of 41 min
resulted at the same time for patients being admitted into
the CDU. Figure 12 supports those benefits and particularly
highlights relative changes where 100% indicates compli-
ance with NICE guidelines and an interval of at least 6 hours
between onset of pain and the blood sample taken (single
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Fig. 12 Relative changes of LOS in ED only and LOS in ED and
CDU respectively – the current setting marks the 100% level
test strategy). In terms of relative changes, the patients still
being admitted for a second sample would benefit signifi-
cantly. The most significant benefits occur in terms of the
number of admissions into CDU and discharges from ED
without admission respectively. Single test strategies mainly
impact the numbers of discharges based on a single test, i.e.
straight from ED, and the related number of admissions to
CDU. Figure 13 outlines a shift from predominantly short
stay admissions and only few discharges towards more dis-
charges. It is worth mentioning that admissions into MAU
were not affected in the what-if analyses. This is the case
because patients admitted into MAU would had a positive
first test, i.e. a troponin concentration of at least 14 ng/litre,
and thus, the number of MAU admissions did not change
with a decreasing time cut-off. Figure 14 shows relative
effects for CDU admissions and discharges based on a sin-
gle test. Admissions to CDU could almost be eliminated,
when allowing a 2 hour delay between the onset of pain and
the time the blood sample was taken. All of those patients
could potentially be discharged on the basis of a single test.
The described effects will likely be less strong in a set-
ting where the average delay between onset of pain and
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Fig. 13 Changes in the number of short stay admissions and dis-
charges when lowering the time cut-off for single test strategy
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Fig. 14 Relative changes of admissions to CDU and discharges based
on a single test – the current setting marks the 100% level
patients presenting at ED is shorter. Similarly, if the pre-
hospital delay was, on average, shorter, this would imply a
higher probability of patients having a blood sample taken
later than the acceptable cut-off time and thus potentially
more patients to be eligible for a single test rule-out strategy.
The outlined impact on admissions and discharges would be
less pronounced when there was a longer delay until pre-
sentation at ED and subsequently a blood sample drawn and
analysed later. Most importantly, however, it is a hospital’s
decision whether or not to be willing to decide on the basis
of a single troponin result given a time delay between onset
of pain and the first blood sample taken. This must not be
interpreted as a recommendation to patients to delay their
attendance to ED in order to potentially save time they spent
in ED.
7 Discussion and outlook
We presented a DES model as part of a bigger study look-
ing at ED pathways for patients presenting with chest pain.
A generic DES model was tailored to represent the situa-
tion at a specific trust. We performed a number of what-if
analyses and investigated the impact of introducing a single
test rule-out strategy where the time cut-off (i.e. the accept-
able timespan between onset of pain and the first sample
at ED) was lowered from 6 hours down to 2 hours. The
currently applied time limit of six hours for single test rule-
out strategies is historical and evidence is available that
the new high-sensitivity troponin tests can reliably rule out
AMI at three hours after symptom onset and shorten patient
waits. Given that the reduction of the time threshold can be
achieved with low additional risk for patients (see for ref-
erence the studies mentioned in Section 2.1), already small
reductions of the time thresholds for single test rule-outs can
significantly increase the number of discharges based on a
single (negative) test.
It should be noted, however, that the model does not
allow to assess the additional level of risk. Therefore, clin-
icians have to make the final decision which time cut-off
for single test strategies is acceptable – this might also vary
across different hospitals. The critical input factor is the
time between onset of worst pain and the first blood sam-
ple taken at ED. The positive effects of avoided admissions
demonstrated in this paper might become more obvious
in settings where there are commonly longer pre-hospital
delays. Finally, the high-sensitivity troponin test is just one
of many factors by which patients presenting with chest pain
are managed within ED. Many such patients can be man-
aged without recourse to it. Our conclusions do not amount
to a recommendation to delay hospital attendance when
experiencing chest pain, rather a central aim of our study is
to help trusts expedite high-sensitivity troponin testing for
those patients who will benefit.
Quantifying the key drivers to decide whether or not
a patient is admitted could be further investigated using
dedicated approaches such as Data Mining or Machine
Learning. This could help to refine the simulation model
with its decision logic in order to explore how additional
knowledge about input factors would affect the accuracy
of the model output. Together with an analysis of the time
since onset of pain and its effects on the outcome, this
could underline the positive impact of our study. Finally,
the developed DES model can easily be tailored around
trust-specific settings which makes it widely applicable,
especially for ACS pathways. It serves primarily as an eval-
uation tool when looking at a possible implementation of
pathway changes at some of the collaborating trusts. The
findings from our project were reported directly to the SW
AHSN and it is hoped that these will inform further policy
directives across the studied hospitals and provide a basis
for a subsequent implementation phase of the work.
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Appendix
We modelled the change of troponin over time for patients
not having either STEMI (ST segment elevation myocardial
infarction) or NSTEMI (non-ST segment elevation myocar-
dial infarction) using moving average processes (MA[q]).
[24] recommends a cut-off level of 14ng/litre for troponin.
Also, studies report that this is a natural and non-elevated
concentration in the blood and can therefore be used as a
cut-off level [37]. The normal level of troponin is denoted
as θ and the error terms  have a mean of μ = 0 and a stan-
dard deviation of σ = 1. The following equation describes
the variation of troponin over time in terms of Xt :
( Xt ) = θ + t − αt−1 − βt−2 − γ t−3 − νt−4t−4 (1)
Figure 15 exemplifies different moving average processes
with a mean of θ = 14. As per the model, we distinguish
patients with cardiac and non-cardiac causes of chest pain.
The latter group can be further divided in musculoskeletal
and other origins. In terms of weights α through γ decreas-
ing effects of previous error terms can be modelled. The
baseline level of troponin, however, does depend on addi-
tional factors such as age or co-morbidities which can easily
be integrated into the model in terms of distinct troponin
profiles. Diagnostic experts of our team suggested that
age-dependent troponin profiles should be included with
further studies, but at the same time confirmed that the vari-
ation shown in Fig. 15 accurately captures variation if age
categories of patients are omitted.
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